Gladstone NOW: The Campaign Join Us on the Journey✕
At Gladstone, we don’t work in isolation. We foster meaningful collaborations and partnerships to help achieve our mission. We’re located in San Francisco, right in the middle of three world-class universities with which we have strong affiliations: UC San Francisco (a partner since our founding in 1979), UC Berkeley, and Stanford University. We’re also connected to the region’s thriving biotech and venture capital ecosystem—this allows us to translate our discoveries into medicines.
Featured Experts
Gladstone NOW: The Campaign
Join Us On The Journey
Industry Partnership Forum Offers Insider Look at Scientific Breakthroughs from Gladstone
Article
August 19, 2024
Industry Partnership Forum Offers Insider Look at Scientific Breakthroughs from Gladstone
The annual event hosted by Gladstone Institutes showcases its most promising scientific discoveries for interested investors and potential industry partners
Corporate Liaison and Ventures Business Development Institutional NewsCNDAP Partners with Takeda to Develop New Therapies for Alzheimer’s Disease and Related Brain Disorders
Article
June 16, 2021
CNDAP Partners with Takeda to Develop New Therapies for Alzheimer’s Disease and Related Brain Disorders
A research collaboration to target the protein tau with small molecules
Business Development News Release Alzheimer’s Disease Neurological Disease Mucke LabNew Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer’s Disease
Article
October 8, 2019
New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer’s Disease
Senior Investigator Katerina Akassoglou has fundamentally changed the way scientists think of neurological disorders. She made the seminal discovery that blood leaks are toxic to the brain by promoting inflammation and destroying neurons. Her research led the scientific community to reassess the complex relationship between the brain, immune, and vascular systems.
Business Development Institutional News Alzheimer’s Disease Multiple Sclerosis Neurological Disease Akassoglou Lab